Keywords: CEST / APT / NOE, CEST / APT / NOE
Motivation: The CEST signal of glucosamine (GlcN), a non-toxic food supplement was previously demonstrated in breast tumors and mouse brains.
Goal(s): To investigate GlcN uptake and efficacy in detecting brain tumors.
Approach: CEST MRI scans (7T) were performed in tumor-bearing mice (n=6) before and after GlcN injection. Data were analyzed using the magnetization transfer ratio asymmetry (MTRasym) metric.
Results: Tumor regions presented signal enhancement compared to the contralateral tissue. The area under the MTRasym curve (1-2.2 ppm) was significantly higher at the tumor (P<0.05).
Impact: This is the first study that examines the use of GlcN for brain tumor imaging. Given its low toxicity and transport capabilities across the blood-brain barrier (BBB), GlcN may be used as a nonmetallic contrast agent for evaluating brain malignancies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords